BLK vs TXG · P/E 27, rev $24.22B vs rev $301.9M
BlackRock Inc (BLK) versus 10X Genomics Inc (TXG) — a side-by-side from cached financials, not a winner call.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.
10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
Latest reported TXG revenue for 2026-06-30 was $301.9M. Net income was -$31.4M. TXG currently screens at market cap $4.08B.
BLK currently screens at market cap $172.19B and trailing P/E 26.6. TXG currently screens at market cap $4.08B.
Not investment advice. Open the BLK and TXG stock pages for the full models.
Not investment advice.